180 related articles for article (PubMed ID: 38192978)
1. Identification of enhancer RNA
Jia L; Chen J; Zhao J; Yang J
Transl Cancer Res; 2023 Dec; 12(12):3266-3283. PubMed ID: 38192978
[TBL] [Abstract][Full Text] [Related]
2. LncRNA AC007255.1, an immune-related prognostic enhancer RNA in esophageal cancer.
Wang Q; Yu X; Yang N; Xu L; Zhou Y
PeerJ; 2021; 9():e11698. PubMed ID: 34316393
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of an immune-related gene signature and infiltrating tumor immune cells based on bioinformatics analysis in primary esophageal cancer.
Du H; Pang S; Li Y; Zhu L; Hang J; Chen L
J Gastrointest Oncol; 2022 Aug; 13(4):1556-1570. PubMed ID: 36092327
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma.
Cai S; Hu X; Chen R; Zhang Y
Front Genet; 2021; 12():657051. PubMed ID: 34178028
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
[TBL] [Abstract][Full Text] [Related]
6. Identifies microtubule-binding protein
Wang W; Zhang J; Wang Y; Xu Y; Zhang S
Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the Immune Infiltration Landscape and Identification of Prognostic Biomarkers for Esophageal Cancer.
Chen Y; Huang X; Chen L; Weng G; Huang Z; Zhang Y; Xiao T; Chen J; Zhu K; Xu Y
Mol Biotechnol; 2023 Mar; 65(3):361-383. PubMed ID: 35780460
[TBL] [Abstract][Full Text] [Related]
8. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
9. Systematic investigation of the clinical significance and prognostic value of the CBXs in esophageal cancer.
Hou J; Yang Y; Gao H; Ouyang T; Liu Q; Ding R; Kan H
Medicine (Baltimore); 2022 Oct; 101(40):e30888. PubMed ID: 36221371
[TBL] [Abstract][Full Text] [Related]
10.
Liu SP; Li XM; Liu DM; Xie SH; Zhang SB; Li Y; Xie ZF
Front Oncol; 2022; 12():884448. PubMed ID: 35530327
[TBL] [Abstract][Full Text] [Related]
11.
Zhang R; Wang H; Xiao J; Lu J; Li M; Zhou Y; Sun H; Liu L; Huang T; Zhao Q
DNA Cell Biol; 2023 Jan; 42(1):27-42. PubMed ID: 36638349
[TBL] [Abstract][Full Text] [Related]
12. Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies.
Yu XW; She PW; Chen FC; Chen YY; Zhou S; Wang XM; Lin XR; Liu QL; Huang ZJ; Qiu Y
BMC Cancer; 2024 Feb; 24(1):230. PubMed ID: 38373930
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of DPY30 as a prognostic biomarker and tumor immune microenvironment infiltration characterization in esophageal cancer.
Mei PY; Xiao H; Guo Q; Meng WY; Wang ML; Huang QF; Liao YD
Oncol Lett; 2023 Feb; 25(2):68. PubMed ID: 36644145
[TBL] [Abstract][Full Text] [Related]
14. CDKL3 shapes immunosuppressive tumor microenvironment and initiates autophagy in esophageal cancer.
Bi Y; Liu J; Qin S; Ji F; Zhou C; Yang H; Zhou S
Front Immunol; 2024; 15():1295011. PubMed ID: 38562942
[TBL] [Abstract][Full Text] [Related]
15. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
16. Identification of clinical prognostic features of esophageal cancer based on m6A regulators.
Wang H; Zhang Y; Chen L; Liu Y; Xu C; Jiang D; Song Q; Wang H; Wang L; Lin Y; Chen Y; Chen J; Xu Y; Hou Y
Front Immunol; 2022; 13():950365. PubMed ID: 36159855
[TBL] [Abstract][Full Text] [Related]
17. Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma.
Wu P; Shi J; Wang Z; Sun W; Zhang H
Cancer Cell Int; 2022 Oct; 22(1):307. PubMed ID: 36217201
[TBL] [Abstract][Full Text] [Related]
18. Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types.
Wu Y; Huang W; Xie Y; Wang C; Luo N; Chen Y; Wang L; Cheng Z; Gao Z; Liu S
Front Mol Biosci; 2022; 9():743515. PubMed ID: 35372497
[TBL] [Abstract][Full Text] [Related]
19. eIF6 is potential diagnostic and prognostic biomarker that associated with
Gao Y; Yuan L; Zeng J; Li F; Li X; Tan F; Liu X; Wan H; Kui X; Liu X; Ke C; Pei Z
J Transl Med; 2022 Jul; 20(1):303. PubMed ID: 35794622
[TBL] [Abstract][Full Text] [Related]
20. Construction of lncRNA prognostic model related to cuproptosis in esophageal carcinoma.
Zhang L; Zong L; Li W; Ning L; Zhao Y; Wang S; Wang L
Front Genet; 2023; 14():1120827. PubMed ID: 37124619
[No Abstract] [Full Text] [Related]
[Next] [New Search]